1. 1088PAnalysis of immune and genomic landscapes of patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with pembrolizumab in the INSPIRE study. (23rd October 2018) Authors: Oliva Bernal, M; Lien, S; Wang, B X; Yang, S C; Spreafico, A; Jang, R; Elston, S; Jennings, S; Jiang, H; Haibe-Kains, B; Pugh, T; Ohashi, P; Siu, L L; Hansen, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 263 Discordant mismatch repair protein expression in synchronous endometrial and ovarian cancers. (13th November 2020) Authors: Kim, S; Tone, A; Pollett, A; Kim, R; Cesari, M; Clarke, B; Eiriksson, L; Hart, T; Holter, S; Lytwyn, A; Maganti, M; Oldfield, L; Pugh, T; Gallinger, S; Bernardini, M; Oza, A; Dube, V; Lerner-Ellis, J; Van de Laar, E; Vicus, D Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 29 Comprehensive molecular assessment of mismatch repair deficiency in lynch-associated ovarian cancers using next-generation sequencing (NGS) panel. (13th November 2020) Authors: Kim, S; Oldfield, L; Tone, A; Pollette, A; Van de Laar, E; Pederson, S; Wellum, J; Clarke, B; Pugh, T; Ferguson, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 340 Performance characteristics of screening strategies to identify Lynch syndrome in women with non-serous and non-mucinous ovarian cancer. (13th November 2020) Authors: Kim, S; Tone, A; Pollett, A; Cesari, M; Clarke, B; Eiriksson, L; Hart, T; Holter, S; Lytwyn, A; Maganti, M; Oldfield, L; Pugh, T; Gallinger, S; Bernardini, M; Oza, A; Vicus, D; Dube, V; Kim, R; Ferguson, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 5 Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study. (13th November 2020) Authors: Kim, S; Tone, A; Pollett, A; Kim, R; Cesari, M; Clarke, B; Eiriksson, L; Hart, T; Holter, S; Lytwyn, A; Maganti, M; Oldfield, L; Pugh, T; Gallinger, S; Bernardini, M; Oza, A; Dube, V; Lerner-Ellis, J; Van de Laar, E; Vicus, D Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 95PPredicting toxicity and response to pembrolizumab (P) through germline genomic HLA class I analysis. (23rd October 2018) Authors: Iafolla, M; Yang, C; Chandran, V; Pintilie, M; Hansen, A; Bedard, P; Lheureux, S; Spreafico, A; Razak, A; Ohashi, P; Hakgor, S; Giesler, A; Pugh, T; Siu, L L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1α. Issue 4 (5th December 2007) Authors: Zahir, F R; Baross, A; Delaney, A D; Eydoux, P; Fernandes, N D; Pugh, T; Marra, M A; Friedman, J M Journal: Journal of medical genetics Issue: Volume 45:Issue 4(2008) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗